Hypoglycemia Management
Immediate Treatment
- For hypoglycemic patients unable to take oral glucose, administer intravenous dextrose in 5-10 gram aliquots, repeating every minute until symptoms resolve or blood glucose exceeds 70 mg/dL, with a maximum total dose of 25 grams, as recommended by the American College of Physicians 1
- Administer 15-20 grams of oral glucose as first-line treatment for conscious patients who can swallow, according to the American Diabetes Association 2
- Recheck blood glucose every 15 minutes and repeat treatment if glucose remains <70 mg/dL, as suggested by the European Association for the Study of Diabetes 3, 2
- Oral glucose should never be given to patients who are unconscious or unable to protect their airway, as stated by the American Heart Association 1
Critical Monitoring and Adjustment
- Check blood glucose before initial dextrose administration and recheck at 15 minutes post-treatment, as recommended by the American College of Physicians 1
- Continue monitoring every 1-2 hours if patient is on insulin infusion, according to the American Diabetes Association 1
- Stop any insulin infusion immediately when treating hypoglycemia to prevent recurrence, as suggested by the European Association for the Study of Diabetes 1
Special Population Considerations
- Treat blood glucose <100 mg/dL in neurologic injury patients, rather than the standard <70 mg/dL threshold, as recommended by the American College of Physicians 1
- Patients with diabetes may require insulin supplementation after treatment to prevent rebound hyperglycemia, according to the American Diabetes Association 1
Post-Treatment Protocol
- Once symptoms resolve and glucose normalizes, provide starchy or protein-rich foods if more than 1 hour until next meal, as suggested by the European Association for the Study of Diabetes 3
- Any severe hypoglycemic episode requiring external assistance mandates reevaluation of the diabetes management plan, according to the American College of Physicians 2
- Investigate underlying causes including medication timing, reduced oral intake, or interruption of nutrition, as recommended by the American Medical Association 4, 5
Common Pitfalls to Avoid
- Do not use 5% dextrose solutions in acute stroke patients, as they can worsen cerebral edema; use isotonic solutions instead, as stated by the American Heart Association 1
- Avoid sliding-scale insulin alone in hospitalized patients, as this is strongly discouraged by the American Medical Association 4, 5
- Never administer oral glucose to unconscious patients, use IV dextrose or IM glucagon instead, as recommended by the American College of Physicians 1
Management of Hypoglycemia in Hospitalized Patients
Immediate Management and Insulin Regimens
- The American Diabetes Association recommends documenting all hypoglycemic episodes in the medical record to track episodes and identify patterns 6
- For NPO patients, the preferred insulin regimen is basal insulin plus correction doses only, not sliding scale insulin alone, as recommended by the American Diabetes Association 6, 7
- Sliding scale insulin as the sole method is strongly discouraged for NPO patients, as it can lead to both hyper- and hypoglycemia 6, 7, 8
- Basal insulin doses should be adjusted downward when a patient becomes NPO to prevent hypoglycemia 8, 9
Preventing Recurrence and Common Triggering Events
- Severe hypoglycemic episodes requiring external assistance mandate reevaluation of the diabetes management plan, according to the American Diabetes Association 6, 7
- Investigate and correct preventable causes of hypoglycemia, including inappropriate timing of insulin, failure to reduce insulin doses when NPO, and unexpected interruption of enteral feedings or parenteral nutrition 8, 9, 10
- Reduced infusion rate of intravenous dextrose and sudden reduction of corticosteroid dose can also trigger hypoglycemia 8, 9
Critical Pitfalls to Avoid and Special Considerations
- The American Diabetes Association advises against relying on sliding scale insulin alone for NPO patients, as this reactive approach can lead to both hyper- and hypoglycemia 6, 9
- Review of the patient's treatment regimen is necessary any time blood glucose <70 mg/dL occurs, as recommended by the American Diabetes Association 10
- A standardized hospital-wide, nurse-initiated hypoglycemia treatment protocol should be implemented to ensure timely and effective treatment 10
Management of Hypoglycemia in NPO Patients
Monitoring and Insulin Management
- The American Diabetes Association recommends monitoring blood glucose every 4-6 hours minimum while NPO, with increased frequency to every 1-2 hours if hypoglycemia has occurred or if patient is on insulin infusion 11, 12
- The American Diabetes Association suggests giving basal insulin at 60-80% of usual dose (or half of NPH dose) to prevent both ketosis and hypoglycemia 11, 12
- The American Diabetes Association recommends using basal insulin plus correction doses only, as the preferred regimen for NPO patients 13
- The American Diabetes Association explicitly states that sliding-scale insulin alone is strongly discouraged as the sole method of insulin treatment in NPO patients 13, 14
Prevention and Treatment
- The American Diabetes Association recommends targeting blood glucose range of 80-180 mg/dL (4.4-10.0 mmol/L) for perioperative and NPO patients 11, 12
- The Joint Commission recommends evaluating all hypoglycemic episodes for root cause, and aggregating and reviewing episodes to address systemic issues 11
Special Considerations
- For type 1 diabetic patients who are NPO, intravenous insulin infusion is the preferred method over subcutaneous administration 14
- These patients must continue receiving basal insulin even when NPO to prevent diabetic ketoacidosis 12
- Inappropriate timing of short- or rapid-acting insulin in relation to NPO status is a common precipitating factor for hypoglycemia 13, 14
Insulin Management for NPO Hospital Patients
Recommended Insulin Regimen
- The American Diabetes Association recommends administering basal insulin at a reduced dose, typically 0.1-0.25 units/kg/day for insulin-naive patients or those on low doses at home, as part of a basal-plus-correction approach 15, 16
- The American College of Physicians suggests adding correction doses of rapid-acting insulin every 4-6 hours or before scheduled glucose checks 17, 18
- For patients already on home insulin at doses ≥0.6 units/kg/day, the Endocrine Society recommends reducing the total daily dose by 20% to prevent hypoglycemia 16
Critical Monitoring Requirements
- The American Association of Clinical Endocrinologists recommends checking blood glucose every 4-6 hours minimum while NPO 19, 18
- The American Diabetes Association suggests targeting a glucose range of 140-180 mg/dL for most noncritically ill patients 17, 19
What NOT to Do
- The American Diabetes Association strongly discourages using only correction/supplemental insulin without basal insulin for NPO patients, as it can lead to both hyperglycemia and hypoglycemia 20, 21
Special Considerations by Patient Type
- The Endocrine Society recommends never using sliding scale insulin alone in type 1 diabetes 16
- The Society of Critical Care Medicine suggests using continuous intravenous insulin infusion as the most effective method for achieving glycemic targets in critically ill patients 20, 21
- The American College of Physicians recommends targeting a glucose range of 140-180 mg/dL for most critically ill patients 17, 19
Transitioning from IV to Subcutaneous Insulin
- The American Association of Clinical Endocrinologists recommends administering subcutaneous basal insulin 1-2 hours before stopping the IV infusion when discontinuing intravenous insulin infusion 17, 20, 21
- The American Diabetes Association suggests converting to basal insulin at 60-80% of the 24-hour IV insulin dose 17
- This transition protocol is associated with lower morbidity and costs of care, according to the American College of Physicians 17, 20